BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33119591)

  • 41. Rising population cost for treating people living with HIV in the UK, 1997-2013.
    Mandalia S; Mandalia R; Lo G; Chadborn T; Sharott P; Youle M; Anderson J; Baily G; Brettle R; Fisher M; Gompels M; Kinghorn G; Johnson M; McCarron B; Pozniak A; Tang A; Walsh J; White D; Williams I; Gazzard B; Beck EJ;
    PLoS One; 2010 Dec; 5(12):e15677. PubMed ID: 21209893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of methods for estimating the cost of human immunodeficiency virus-testing interventions.
    Shrestha RK; Sansom SL; Farnham PG
    J Public Health Manag Pract; 2012; 18(3):259-67. PubMed ID: 22473119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bottlenecks and opportunities for delivering integrated pediatric HIV services in Nepal.
    Diese M; Shrestha L; Pradhan B; Singh D; Raaijmakers H; Kisesa A; Chamla D; Ntambue MA
    Curr Opin HIV AIDS; 2016 Mar; 11 Suppl 1(Suppl 1):S21-9. PubMed ID: 26945139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implementation of a standardized HIV patient monitoring system in Guyana.
    Halpern M; Lachmansingh B; Minior T; Hasbrouck LM; Persaud N; Foo A
    Rev Panam Salud Publica; 2010 Aug; 28(2):107-13. PubMed ID: 20963277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resource needs for adolescent friendly health services: estimates for 74 low- and middle-income countries.
    Deogan C; Ferguson J; Stenberg K
    PLoS One; 2012; 7(12):e51420. PubMed ID: 23300548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Costs along the service cascades for HIV testing and counselling and prevention of mother-to-child transmission.
    Bautista-Arredondo S; Sosa-Rubí SG; Opuni M; Contreras-Loya D; Kwan A; Chaumont C; Chompolola A; Condo J; Galárraga O; Martinson N; Masiye F; Nsanzimana S; Ochoa-Moreno I; Wamai R; Wang'ombe J;
    AIDS; 2016 Oct; 30(16):2495-2504. PubMed ID: 27753679
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost of delivering health care services at primary health facilities in Ghana.
    Dalaba MA; Welaga P; Matsubara C
    BMC Health Serv Res; 2017 Nov; 17(1):742. PubMed ID: 29149853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The potential for quality assurance systems to save costs and lives: the case of early infant diagnosis of HIV.
    Terris-Prestholt F; Boeras D; Ong JJ; Torres-Rueda S; Cassim N; Mbengue MAS; Mboup S; Mwau M; Munemo E; Nyegenye W; Odhiambo CO; Dabula P; Sandstrom P; Sarr M; Simbi R; Stevens W; Tucker JD; Vickerman P; Ciaranello A; Peeling RW
    Trop Med Int Health; 2020 Oct; 25(10):1235-1245. PubMed ID: 32737914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The costs of treating HIV-infected children in Abidjan, Ivory Coast, 1996-1997].
    Giraudon I; Leroy V; Msellati P; Elenga N; Ramon R; Welffens-Ekra C; Dabis F
    Sante; 1999; 9(5):277-81. PubMed ID: 10657769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Funding antiretroviral treatment for HIV-positive temporary residents in Australia prevents transmission and is inexpensive.
    Gray RT; Watson J; Cogle AJ; Smith DE; Hoy JF; Bastian LA; Finlayson R; Drummond FM; Whittaker B; Law MG; Petoumenos K
    Sex Health; 2018 Feb; 15(1):13-19. PubMed ID: 28874236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Costing of scaling up HIV/AIDS treatment in Mexico.
    Bautista-Arredondo S; Dmytraczenko T; Kombe G; Bertozzi SM
    Salud Publica Mex; 2008; 50 Suppl 4():S437-44. PubMed ID: 19082254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost and cost-effectiveness of transitioning to universal initiation of lifelong antiretroviral therapy for all HIV-positive pregnant and breastfeeding women in Swaziland.
    Cunnama L; Abrams EJ; Myer L; Gachuhi A; Dlamini N; Hlophe T; Kikuvi J; Langwenya N; Mthethwa S; Mudonhi D; Nhlabatsi B; Nuwagaba-Biribonwoha H; Okello V; Sahabo R; Zerbe A; Sinanovic E
    Trop Med Int Health; 2018 Sep; 23(9):950-959. PubMed ID: 29956426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The cost of HIV disease in Northern Italy: the payer's perspective.
    Rizzardini G; Restelli U; Bonfanti P; Porazzi E; Ricci E; Casartelli L; Foglia E; Carenzi L; Citterio P; Orlando G; Maselli C; Croce D
    J Acquir Immune Defic Syndr; 2011 Jul; 57(3):211-7. PubMed ID: 21546850
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Costs of HIV/AIDS treatment in Indonesia by time of treatment and stage of disease.
    Siregar AY; Tromp N; Komarudin D; Wisaksana R; van Crevel R; van der Ven A; Baltussen R
    BMC Health Serv Res; 2015 Sep; 15():440. PubMed ID: 26424195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resource utilization and direct costs of pediatric HIV in Italy.
    Giacomet V; Fabiano V; Lo Muto R; Caiazzo MA; Curto A; Rampon O; Zuccotti GV; Garattini L
    AIDS Care; 2013; 25(11):1392-8. PubMed ID: 23414422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost analysis of two community-based HIV testing service modalities led by a Non-Governmental Organization in Cape Town, South Africa.
    Meehan SA; Beyers N; Burger R
    BMC Health Serv Res; 2017 Dec; 17(1):801. PubMed ID: 29197386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changing cost of HIV interventions in the context of scaling-up in India.
    Dandona L; Kumar SP; Ramesh Y; Rao MC; Kumar AA; Marseille E; Kahn JG; Dandona R
    AIDS; 2008 Jul; 22 Suppl 1(0 1):S43-9. PubMed ID: 18664952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa--a primary data analysis.
    Cleary SM; McIntyre D; Boulle AM
    Cost Eff Resour Alloc; 2006 Dec; 4():20. PubMed ID: 17147833
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The determinants of HIV treatment costs in resource limited settings.
    Menzies NA; Berruti AA; Blandford JM
    PLoS One; 2012; 7(11):e48726. PubMed ID: 23144946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.